Provider
QP18-20 Pharmacy Benefit Exclusion for Calcipotriene-Betamethasone Dipropionate Suspension 0.005-0.064% (authorized generic (AG) of Taclonex suspension)
Program effective Date: Feb 12, 2020
Program effective Date: Feb 12, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Feb 03, 2020
Program effective Date: Jan 22, 2020